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E-mail address: maturana@vos.nagaokaut.ac.jp (A.Protein kinase D (PKD) regulates the activity of the L-type calcium channel in rat ventricular cardio-
myocytes. However, the functional target residues of PKD on the L-type calcium channel remain to
be identiﬁed. Our aim was to identify the functional phosphorylation sites of PKD on the human L-
type calcium channel. The pore subunit of the human CaV1.2 (hCaV1.2) was stably expressed in
HEK293 cells. Both the expression of a dominant-negative mutant of PKD and the mutation of serine
1884 but not serine 1930, putative targets of PKD, strongly reduced L-type calcium currents and sin-
gle channel activity without affecting the channel’s expression at the plasma membrane. Our results
suggest that serine 1884 is essential for the regulation of hCaV1.2 by PKD.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
L-type voltage-gated calcium channels are themajor gate for the
entry of calcium into the cytosol of many cell types such as neurons,
myocytes and endocrine cells [1]. These channels play an essential
role in the excitation-contraction coupling of muscle contraction,
hormone secretion, transcription and neuronal activity [1]. In the
heart, the calcium entering through the L-type voltage-gated cal-
cium channels initiates the cardiac contraction. Cardiac L-type
calcium channels are also involved in cardiac arrhythmia and heart
failure [2]. In response to stress and neuro-humoral stimulation, the
activity of L-type calcium channels is acutely modiﬁed by post-
translational modiﬁcation, mainly phosphorylation [3]. The regula-
tion of the cardiac L-type calcium channel by various protein ki-
nases, particularly Protein Kinase A (PKA) and Protein Kinase C
(PKC), has been extensively studied [4].
Protein kinase D is a serine/threonine kinase playing an impor-
tant role in the heart [5]. We have shown that the cardiac L-type
calcium channel is regulated by PKD upon a-adrenergic stimula-
tion in ventricular cardiomyocytes of newborn rats [6]. The regula-
tion of L-type calcium channel by PKD was subsequently conﬁrmed
to occur in adult rat cardiomyocytes [7].chemical Societies. Published by E
D. Maturana).The mechanisms of this regulation and whether the human
L-type calcium channel is regulated by PKD have not yet been
studied. Analysis of the amino-acid sequence of the pore subunit
of the L-type calcium channel, CaV1.2, showed two serine residues
possess an amino-acid sequence speciﬁc for PKD. Both residues
and their neighboring sequence are fully conserved in various spe-
cies [8]. In the present study, we aimed at testing the functional
role of these two serine residues, potential targets of PKD, in the
regulation of the human cardiac L-type calcium channel activity.
2. Materials and methods
For this study, L-type calcium currents were measured by
patch-clamp in the whole-cell and cell-attached conﬁguration
from HEK293 cells stably expressing the human CaV1.2. Expression
of hCaV1.2 and mutants was veriﬁed by western blot (WB) and cell
surface biotinylation. Details of Section 2 are found in
Supplementary data.
3. Results
3.1. Protein kinase D regulates the basal activity of the human CaV1.2
We have previously shown that in ventricular cardiomyocytes
of newborn rats, protein kinase D (PKD) regulates the activity of
the L-type calcium channels upon a-adrenergic stimulation [6].lsevier B.V. All rights reserved.
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channel is also regulated by PKD. For this purpose, we established
a stable cell line co-expressing the human CaV1.2 (hCaV1.2) pore
subunit with the human b2a subunit. The expression of hCaV1.2
was under the control of a tetracycline-inducible promoter. The
expression of hCaV1.2 was strongly induced 24–48 h after the
addition of 20 lg/ml of doxycycline (Fig. 1A). In these cells, L-type
calcium currents could be measured by eliciting 200 ms voltage
depolarization steps from 90 to +70 mV from a holding potential
of 90 mV in the whole-cell conﬁguration of the patch-clamp
technique (Fig. 1B).
Because no speciﬁc activator or inhibitor of PKD are commer-
cially available, we used a constitutive active mutant of PKD tagged
withagreenﬂuorescentprotein (GFP-PKD-CA)andadominant-neg-
ative mutant of PKD (GFP-PKD-DN) [9,10] to investigate the regula-
tion of the human L-type calcium channel by PKD. GFP-PKD-CA
expression did not change the amplitude of the L-type calcium
current density compared to the control (Fig. 1B). However, in
hCaV1.2-HEK293 cells expressing GFP-PKD-DN, L-type calcium cur-
rents were signiﬁcantly reduced between +20 and +40 mV (Fig. 1B).
These results suggested the activity of the human cardiac L-type
calcium channel might be regulated at the basal level by PKD.
To test this hypothesis, we measured the activity of the L-type
calcium channel at the single channel level in the cell-attach con-
ﬁguration (Supplementary data Fig. S1). The single channel activity
was observed in both GFP-PKD-DN and GFP-PKD-CA expressingDoxycycline
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Fig. 1. PKD regulates the activity of human L-type calcium channel. (A)WB showing
doxycycline induction of hCaV1.2 at 24 h and 48 h (n = 3). (B) Traces of calcium
currents recorded at 10 mV voltage steps from a -90 mV holding potential to +70 mV
of control cells or cells transfected with GFP-PKD-DN or GFP-PKD-CA. 40 mM Ca2+
was used as a charge carrier. The graph is the current density-voltage relationships of
control (circles, n = 12), GFP-PKD-DN (triangles, n = 11) and GFP-PKD-CA (squares,
n = 7) cells (mean and s.e.m). ⁄ is P < 0.02.cells, however, the frequency of spontaneous events was much
lower when cells expressing the dominant-negative mutant of
PKD (Fig. 2A). The open probability in cells expressing GFP-PKD-
DN was signiﬁcantly reduced compare to control cells or to GFP-
PKD-CA expressing cells (Fig. 2B). These results corroborate the
observation made in the whole-cell experiments and suggest that
PKD regulates the activity of the human L-type calcium channel.
3.2. Ser 1884 but not S1930 is important for the PKD-dependent
regulation of the human L-type calcium channel
We next aimed at identifying the functional target residues of
PKD on the hCaV1.2. The amino-acid sequence of the hCaV1.2
showed two serine residues in the C-terminal domain of hCaV1.2
with an amino-acid context speciﬁc for PKD: LXRXXS [8]: Ser
1884 and Ser 1930 (Fig. 3A). To investigate their functional role
these residues were mutated to alanine, individually: Ser1884 to
Ala1884 (S1884A) and Ser1930 to Ala1930 (S1930A) or both
together (S1884A/S1930A). Mutated hCaV.1.2 was also stably ex-
pressed in HEK293 cells. WB analysis showed that the expression
of all three hCaV1.2 mutants was not modiﬁed compare to the
wild-type hCaV1.2 at 24 and 48 h after the induced-expression
(Fig. 3B). On the same PVDF membrane, the detection of a-tubulin
was used as a loading control. In addition, the mutations did not
affect the expression of hCaV1.2 at the surface of the plasma mem-
brane as shown by the cell surface biotinylation experiment. No
difference in surface expression of the serine-mutated hCaV1.2
was observed compared to the wild-type hCaV1.2 (Figs. 3C andA
B
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Fig. 2. Single channel activity of hCaV1.2 in cells expressing GFP-PKD-DN or GFP-
PKD-CA. (A) Traces of single channel activity recorded in the cell-attached conﬁg-
uration of hCaV12 cells using 100 mM Ba2+ as a charge carrier and in presence of
0.2 lMBayK8644 (B)Meanof the openprobability of the control (n = 9), GFP-PKD-DN
(n = 8) or GFP-PKD-CA (n = 6) expressing cells. ⁄ is P < 0.002.
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Fig. 3. Expression of hCaV1.2 andmutants. (A) Schematic representation of hCaV1.2
showing the two serine residues with a PKD speciﬁc consensus sequence. (B) WBs
showing the expression of hCaV1.2 wild-type and mutants (upper) and b-tubulin
(lower) on the same membrane at 24 or 48 h after doxycycline addition (n = 5). (C)
Cell-surface biotinylation analysis of hCaV1.2 (WTandmutants) and b1 integrinwere
detected by WB on the same membrane (n = 8).
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Fig. 4. Effect of S1884 and S1930 mutations on L-type calcium currents. L-type
calcium currents were measured in HEK293 stably expressing S1884A, S1930A, and
S1884A/S1930A mutants of hCaV1.2 by patch-clamp in the whole-cell conﬁgura-
tion. 40 mM Ca2+ was used as a charge carrier. Panels A to C are the current density-
voltage relationships recorded by 10 mV voltage steps ranging from -90 mV to
+80 mV. Currents were measured in (A) S1884A (n = 10), (B) S1930A (n = 11), and
(C) S1884A/S1930A (n = 10) expressing cells (squares). Curves with circles are from
cells transfected with GFP-PKD-DN in (A) S1884A (n = 8), (B) S1930A (n = 6), and (C)
S1884A/S1930A (n = 6). (D) Bar graph shows the mean current density at +30 mV
for WT-CaV1.2 and the mutants. Values are mean and S.E.M. ⁄ is P < 0.05.
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Next, we measured the L-type calcium currents of hCaV1.2
mutants in thewhole-cell conﬁguration. The current density ampli-
tude of the S1884A-hCaV1.2 mutant was signiﬁcantly reduced
compared to the WT-hCaV1.2. The amplitude of the calcium cur-
rents of the S1930A-hCaV1.2 mutant was similar to that of the
wild-type CaV1.2. The hCaV1.2 with both serine residues mutated,
S1884A/S1930A, had signiﬁcantly reduced current density ampli-
tude than theWT-hCaV1.2 (Figs. 1B and 4A and B). The transfection
of GFP-PKD-DN did not further affect the L-type calcium currents of
S1884A-hCaV1.2 and S1884A/S1930A-hCaV1.2 mutants but signif-
icantly reduced the L-type currents of the S1930A mutant (Fig. 4A).
We also veriﬁed if the current reduction of these mutants occurs
at the single channel level using the cell-attached conﬁguration
(Fig. 5A). The activity of S1884A and S1884A/S1930A hCaV1.2 mu-
tants was reduced compared to the WT-hCaV1.2 (Figs. 2A and 5A).
Accordingly, the channel open probabilities of S1884A-hCaV1.2
and S1884A/S1930A-hCaV1.2mutants were signiﬁcantly decreased
compare to that of the WT-hCaV1.2 (Fig. 5B). Taken together, these
results suggested that S1884, but not S1930, is essential for the
activity of the human cardiac L-type calcium channel.
These results suggested us that S1884 might be phosphorylated
in hCaV1.2-HEK293 cells even in the absence of any external
stimulation. On aWB analysis, using an anti-phosphoS1884, a band
corresponding to the hCaV1.2 was detected in non-stimulated
HEK293 cells expressing WT and S1930A mutated hCaV1.2. How-ever, this band was lacking in cells expressing either hCaV1.2-
S1884A or hCaV1.2-S1884A/S1930A (Fig. 5C, left). The transfection
of GFP-PKD-DN, but not GFP-PKD-CA, strongly reduced the phos-
pho-S1884 band in WT-hCaV1.2 expressing cells in absence of
any stimulation (Fig. 5C, right). These results suggest that S1884
is phosphorylated by PKD at the basal level.4. Discussion
PKD is a recent player in the extensively studied regulation of
the cardiac L-type calcium channel by protein kinases. PKD is of
particular interest because this kinase plays a crucial role in the
heart, regulating the contraction and transcription and now ap-
pears to be also involved in the regulation of the calcium cycling
of cardiomyocytes [5–7]. The present study brings evidence show-
ing that PKD regulates the activity of the human cardiac L-type cal-
cium channels and identiﬁes S1884 as the functional serine target
of PKD on the C-terminal domain of hCaV1.2. In addition, our re-
sults exclude S1930, another potential target of PKD on hCaV1.2,
as a functional residue for the regulation of the human L-type
calcium channel activity.
Our results showed that consistently the mutation of S1884 or
GFP-PKD-DN reduced the L-type calcium current of CaV1.2 ex-
pressed in HEK293 cells. In addition, the GFP-PKD-DN had no effect
on the currents of S1884A-hCaV1.2 mutants. These results thus
ApS1884
HE
K2
93
250 kDa
CaV1.2-S1930A
CaV1.2-S1884A
0.5 sec
1 pA
0.5 sec
1 pA
0.5 sec
1 pA
CaV1.2-S1884A/S1930A
O
pe
n 
pr
ob
ab
ilit
y
WT S1884A S1930A S1884A/
S1930A
0.00
0.05
0.10
0.15
0.20
*
*
B
C
hC
aV
1.2
-W
T
hC
aV
1.2
-S
19
30
A
hC
aV
1.2
-
   S
18
84
A/
S1
93
0A
hC
aV
1.2
-S
18
84
A
250 kDa pS1884
β−tubulin
hC
aV
1.2
-W
T
hC
aV
1.2
-W
T
+ G
FP
-P
KD
-C
A
hC
aV
1.2
-W
T
+ G
FP
-P
KD
-D
N
β−tubulin
Fig. 5. Effects of the serine mutations on the single L-type calcium channel activity.
(A) Single channel activity recorded in the cell-attached conﬁguration of cells stably
expressing hCaV12 mutants using 100 mM Ba2+ as a charge carrier and in presence
of 0.2 lM BayK8644 (B) Mean and S.E.M. values of the open probability of S1884A
(n = 7), S1930A (n = 5) or S1884A/S1930A (n = 7) expressing cells. ⁄Is P < 0.05. (C)
WB analysis from the same membrane of hCaV1.2 using the anti-pS1884 and a
monoclonal anti-b-tubulin used as a loading control. Left is WT and mutants of
hCaV1.2 (n = 3). Right is WT-hCaV1.2 co-expressed with GFP-PKD-DN (n = 3).
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calcium channel by phosphorylating S1884 residue on the C-termi-
nal domain of hCaV1.2. S1884 of the hCaV1.2 isoform used for this
study correspond to the S1928 of the rabbit CaV1.2 (rCaV1.2). The
phosphorylation of S1928 and its role in the regulation of the rab-
bit cardiac L-type calcium channel has been extensively studied
[4,8,11]. The S1928 of rCaV1.2 is phosphorylated by both the PKA
and various isoform of the PKC upon neuro-humoral stimulations
[8,11]. However, the functional role of S1928 phosphorylation is
still controversial [8,12]. A recent study showed that S1928 of
the rCaV1.2 is phosphorylated by PKD [13]. Here, we found that
on the hCaV1.2, the corresponding S1884 has a functional role in
the regulation of the L-type calcium channel. A possible explana-
tion could be related to a species difference.
The other putative target of PKD on CaV1.2 S1930 has never
been studied. Despite the conservation of the PKD consensus se-
quence among various species, our data showed that S1930 does
not functionally regulate the channel activity of the human cardiac
L-type calcium channel. However, its conservation among various
species suggests a role but maybe not related to the regulation of
the L-type calcium channel activity itself. The C-terminal domain
of CaV1.2 is proteolytically cleaved and this domain acts as a tran-
scriptional regulator [14]. It is possible to speculate that S1930
phosphorylation by PKD might play a role in the transcriptional
function of CaV1.2 C-terminal domain.
L-type calcium currents measured in hCaV1.2-HEK were neither
enhanced nor reduced by a constitutive active mutant of PKDsuggesting that PKD phosphorylation of S1884 occurs at cell resting
state. Indeed, S1884 is phosphorylated in non-stimulated hCaV1.2-
HEK cells. Both PKD-DN or S1884A mutants prevent this phosphor-
ylation on hCaV1.2 suggesting a basal activity of PKD. A recent study
showed that in mouse embryonic cardiomyocytes, PKA, indepen-
dently of an b-adrenergic stimulation, controls a high basal activity
of themouse cardiac L-type calcium channel [15]. It is then possible
to speculate that similarly PKDmight control the activity of the hu-
man L-type calcium channel during the heart development.
In conclusion, our study showed that PKD regulates the activity
of the human L-type calcium channel through the phosphorylation
of S1884, but not S1930, on the C-terminal domain of hCaV1.2.
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